Abstract
Using data from a prostate cancer registry, this study correlated HSD3B1 genotype with response to androgen-deprivation therapy in patients with prostate cancer.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Androgen Antagonists / therapeutic use*
-
Gene Frequency
-
Genotype
-
Germ-Line Mutation*
-
Humans
-
Kaplan-Meier Estimate
-
Male
-
Multienzyme Complexes / genetics*
-
Neoplasm Metastasis
-
Pharmacogenomic Variants
-
Polymorphism, Single Nucleotide
-
Progesterone Reductase / genetics*
-
Prostatectomy
-
Prostatic Neoplasms / drug therapy*
-
Prostatic Neoplasms / genetics
-
Prostatic Neoplasms / surgery
-
Steroid Isomerases / genetics*
-
Treatment Outcome
Substances
-
3 beta-hydroxysteroid oxidoreductase-delta(5) 3-ketosteroid isomerase
-
Androgen Antagonists
-
Multienzyme Complexes
-
Progesterone Reductase
-
Steroid Isomerases